메뉴 건너뛰기
Drugs and Therapy Perspectives
Volumn 10, Issue 11, 1997, Pages 13-16
Benign prostatic hypertrophy: 'Cost-benefits' of surgery greater than that of drug therapy
[No Author Info available]
Author keywords

[No Author keywords available]
Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; FINASTERIDE;
EID: 0030775241     PISSN: 11720360     EISSN: None     Source Type: Journal    
DOI: 10.2165/00042310-199710110-00005     Document Type: Review
Times cited : (1)
References (14)
  • 1
    • 0031046447 scopus 로고    scopus 로고
    • Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective
    • Feb
    • Eri LM, Tveter KJ. Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective. Drugs Aging 1997 Feb; 10 (2): 107-18
    • (1997) Drugs Aging , vol.10 , Issue.2 , pp. 107-118
    • Eri, L.M.1    Tveter, K.J.2
  • 2
    • 0026591918 scopus 로고
    • The measurement committee of the American Urological Association: The American Urological Association symptom index for benign prostatic hyperplasia
    • Barry MJ, Fowler FJ, O'Leary MP, et al. The measurement committee of the American Urological Association: the American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549-57
    • (1992) J Urol , vol.148 , pp. 1549-1557
    • Barry, M.J.1    Fowler, F.J.2    O'Leary, M.P.3
  • 3
    • 0024551135 scopus 로고
    • Transurethral prostatectomy: Immediate and postoperative complications: a cooperative study of 13 participating institutions evaluating 3885 patients
    • Mebust WK, Holtgrewe HL, Cockett ATK, et al. Transurethral prostatectomy: immediate and postoperative complications: a cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989; 141: 243-7
    • (1989) J Urol , vol.141 , pp. 243-247
    • Mebust, W.K.1    Holtgrewe, H.L.2    Cockett, A.T.K.3
  • 4
    • 19144369085 scopus 로고
    • Finasteride: Good tolerability but modest clinical benefit in BPH
    • Aug 30
    • Finasteride: good tolerability but modest clinical benefit in BPH. Drug Ther Perspect 1993 Aug 30; 2 (4): 1-4
    • (1993) Drug Ther Perspect , vol.2 , Issue.4 , pp. 1-4
  • 5
    • 0029164575 scopus 로고
    • Doxazosin: Long-acting α-blocker for hypertension and prostatic hypertrophy
    • Sep 4
    • Doxazosin: long-acting α-blocker for hypertension and prostatic hypertrophy. Drug Ther Perspect 1995 Sep 4; 6 (5): 5-8
    • (1995) Drug Ther Perspect , vol.6 , Issue.5 , pp. 5-8
  • 6
    • 0030805643 scopus 로고    scopus 로고
    • Serenoa repens: A phytotherapeutic agent for benign prostatic hypertrophy
    • Aug 4
    • Serenoa repens: a phytotherapeutic agent for benign prostatic hypertrophy. Drug Ther Perspect 1997 Aug 4; 10 (3): 1-4
    • (1997) Drug Ther Perspect , vol.10 , Issue.3 , pp. 1-4
  • 7
    • 0029052133 scopus 로고
    • Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States
    • Gee WF, Holtgrewe HL, Albertsen PC, et al. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States. J Urol 1995; 154: 205-6
    • (1995) J Urol , vol.154 , pp. 205-206
    • Gee, W.F.1    Holtgrewe, H.L.2    Albertsen, P.C.3
  • 8
    • 8044250332 scopus 로고    scopus 로고
    • Benign prostatic hyperplasia, impact of medical therapy on TURP: A statewide population-based analysis of 26625 patients
    • abstract no. 1481
    • Carson CC, Singla A, Rutledge R. Benign prostatic hyperplasia, impact of medical therapy on TURP: a statewide population-based analysis of 26625 patients [abstract no. 1481]. J Urol 1996; 155: 681A
    • (1996) J Urol , vol.155
    • Carson, C.C.1    Singla, A.2    Rutledge, R.3
  • 9
    • 0028799170 scopus 로고
    • Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study
    • Andersen JT, Ekman P, Wolf H, et al. Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. Urology 1995; 46: 631-7
    • (1995) Urology , vol.46 , pp. 631-637
    • Andersen, J.T.1    Ekman, P.2    Wolf, H.3
  • 10
    • 0029143731 scopus 로고
    • α-Blockade in the treatment of symptomatic benign prostatic hyperplasia
    • Eri LM, Tveter KJ. α-Blockade in the treatment of symptomatic benign prostatic hyperplasia. J Urol 1995; 154: 923-34
    • (1995) J Urol , vol.154 , pp. 923-934
    • Eri, L.M.1    Tveter, K.J.2
  • 11
    • 8044261466 scopus 로고
    • Medical management of benign prostatic hyperplasia (BPH) versus transurethral prostatectomy: The economic consequences
    • abstract no. 883
    • Russell DJ, Kaufman Jr RP, Cain MP. Medical management of benign prostatic hyperplasia (BPH) versus transurethral prostatectomy: the economic consequences [abstract no. 883]. J Urol 1993; 149: 433A
    • (1993) J Urol , vol.149
    • Russell, D.J.1    Kaufman Jr., R.P.2    Cain, M.P.3
  • 12
    • 0001775328 scopus 로고
    • The role of alpha blockade in the therapy of benign prostatic hyperplasia
    • Lepor H, Lawson RK, editors. Philadelphia: WB Saunders
    • Lepor H. The role of alpha blockade in the therapy of benign prostatic hyperplasia. In: Lepor H, Lawson RK, editors. Prostate diseases. Philadelphia: WB Saunders, 1993: 170-81
    • (1993) Prostate Diseases , pp. 170-181
    • Lepor, H.1
  • 13
    • 0028091185 scopus 로고
    • Urologists on a tightrope: Coping with a changing economy
    • Goluboff ET, Olsson CA. Urologists on a tightrope: coping with a changing economy. J Urol 1994; 151: 1-4
    • (1994) J Urol , vol.151 , pp. 1-4
    • Goluboff, E.T.1    Olsson, C.A.2
  • 14
    • 0001656581 scopus 로고    scopus 로고
    • Economics of benign prostatic hyperplasia
    • Kirby R, editor. Oxford: Isis Medical Media
    • Holtgrewe HL. Economics of benign prostatic hyperplasia. In: Kirby R, editor. Textbook of benign prostatic hyperplasia. Oxford: Isis Medical Media, 1996: 527-36
    • (1996) Textbook of Benign Prostatic Hyperplasia , pp. 527-536
    • Holtgrewe, H.L.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.